Liu Yali, Ma Guowei, Li Yumei, Wu Yuanyuan
ENT Department, Xiangyang No.1 People's Hospital, Hubei University of Medicine, Xiangyang, Hubei China.
School of Pharmacy, Department of Pharmacology, China Medical University, Shenyang, Liaoning China.
Indian J Otolaryngol Head Neck Surg. 2024 Dec;76(6):5393-5399. doi: 10.1007/s12070-024-04985-1. Epub 2024 Aug 14.
Sudden Sensorineural Hearing Loss is a common emergency in otolaryngology, with an increasing incidence among younger age groups. This study retrospectively analyzes peripheral blood inflammatory markers in SSNHL patients under 24 years-old to explore the potential prognostic value of the immune inflammatory response in young SSNHL patients. This retrospective analysis included 53 SSNHL patients who received treatment from January 2016 to December 2023. Patients were grouped based on age, gender, and therapeutic effects. Sixty-two healthy volunteers were selected from the hospital physical examination center as the control group. Neutrophil, lymphocyte, and platelet counts were measured to calculate the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Systemic Immune-Inflammation Index (SII). Logistic regression models determined prognostic risk variables, and receiver operating characteristic (ROC) curves calculated the model's predictive accuracy. Compared to the control group, SSNHL patients exhibited increased absolute neutrophil counts, platelet counts, NLR, PLR, and SII, while lymphocyte counts decreased. Male patients showed statistical differences in neutrophil counts, NLR, PLR, and SII, while female patients showed statistical differences in neutrophil counts, NLR, and SII. Statistical differences were observed in platelet counts between males aged ≤ 18 and lymphocyte counts in males aged 18-24. Significant differences in neutrophil counts, NLR, and SII were found between effective and ineffective treatment groups for SSNHL patients aged 18-24. Elevated SII was identified as a risk factor affecting the efficacy of SSNHL treatment in patients aged 18-24. Chronic inflammation is a confirmed pathological and physiological process in SSNHL, necessitating hormone anti-inflammatory therapy for both adults and children.
The online version contains supplementary material available at 10.1007/s12070-024-04985-1.
突发性感音神经性听力损失是耳鼻喉科常见的急症,在年轻人群中的发病率呈上升趋势。本研究回顾性分析24岁以下突发性感音神经性听力损失(SSNHL)患者的外周血炎症标志物,以探讨免疫炎症反应在年轻SSNHL患者中的潜在预后价值。这项回顾性分析纳入了2016年1月至2023年12月期间接受治疗的53例SSNHL患者。根据年龄、性别和治疗效果对患者进行分组。从医院体检中心选取62名健康志愿者作为对照组。测量中性粒细胞、淋巴细胞和血小板计数,以计算中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)和全身免疫炎症指数(SII)。逻辑回归模型确定预后风险变量,受试者工作特征(ROC)曲线计算模型的预测准确性。与对照组相比,SSNHL患者的中性粒细胞绝对计数、血小板计数、NLR、PLR和SII升高,而淋巴细胞计数降低。男性患者在中性粒细胞计数、NLR、PLR和SII方面存在统计学差异,而女性患者在中性粒细胞计数、NLR和SII方面存在统计学差异。≤18岁男性的血小板计数与18 - 24岁男性的淋巴细胞计数存在统计学差异。18 - 24岁SSNHL患者的有效治疗组和无效治疗组在中性粒细胞计数、NLR和SII方面存在显著差异。SII升高被确定为影响18 - 24岁SSNHL患者治疗效果的危险因素。慢性炎症是SSNHL中已证实的病理生理过程,成人和儿童均需要激素抗炎治疗。
在线版本包含可在10.1007/s12070 - 024 - 04985 - 1获取的补充材料。